A Second Phase III, 4-Week Clinical Trial to Evaluate Rhopressa (Netarsudil Ophthalmic Solution) in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 15 Mar 2023

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

22 Jun 2021 New trial record
17 Jun 2021 According to an Aerie Pharmaceuticals media release, the expect to conduct a total of three Phase 3 clinical trials for Rhopressa in Japan, two 4-week trials (CT profiles 306181 and 338663) and one 12-month safety trial (CT profile 338664).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com